Massimo Mirandola

2.4k total citations · 1 hit paper
77 papers, 1.1k citations indexed

About

Massimo Mirandola is a scholar working on Infectious Diseases, Epidemiology and Sociology and Political Science. According to data from OpenAlex, Massimo Mirandola has authored 77 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 26 papers in Epidemiology and 19 papers in Sociology and Political Science. Recurrent topics in Massimo Mirandola's work include HIV/AIDS Research and Interventions (21 papers), HIV, Drug Use, Sexual Risk (18 papers) and LGBTQ Health, Identity, and Policy (13 papers). Massimo Mirandola is often cited by papers focused on HIV/AIDS Research and Interventions (21 papers), HIV, Drug Use, Sexual Risk (18 papers) and LGBTQ Health, Identity, and Policy (13 papers). Massimo Mirandola collaborates with scholars based in Italy, United Kingdom and Belgium. Massimo Mirandola's co-authors include Francesco Amaddeo, Lorenzo Gios, Ulrich Marcus, Graham Dunn, Cinta Folch, Michele Tansella, Axel J. Schmidt, John E. Pachankis, Nigel Sherriff and Massimo Santinello and has published in prestigious journals such as PLoS ONE, Scientific Reports and The British Journal of Psychiatry.

In The Last Decade

Massimo Mirandola

72 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mental health in transgender individuals: a systematic review

2022 84 citations Federica Pinna, Antonio Ventriglio et al. profile →

Peers

Countries citing papers authored by Massimo Mirandola

Since Specialization

Citations

This map shows the geographic impact of Massimo Mirandola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Mirandola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Mirandola more than expected).

Fields of papers citing papers by Massimo Mirandola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Mirandola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Mirandola. The network helps show where Massimo Mirandola may publish in the future.

Co-authorship network of co-authors of Massimo Mirandola

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Mirandola. A scholar is included among the top collaborators of Massimo Mirandola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Mirandola. Massimo Mirandola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence and epidemiology of Mycoplasma genitalium and the absence of macrolide resistance in M. genitalium among pregnant women attending antenatal care in Zambia 2025 ·Frontiers in Public Health ·(unknown), (unknown), Elena V. Shipitsyna, Enesia Banda Chaponda, Daniel Golparian, (unknown), (unknown), (unknown), Mike Chaponda, Chris Smith, Mitsuaki Matsui, Massimo Mirandola, Karel Blondeel, Igor Toskin, R Matthew Chico, Magnus Unemo	0
2	Infectious diseases ethics: a worldwide survey 2024 ·Clinical Microbiology and Infection ·Elda Righi, Massimo Mirandola, Alessandra Agnese Grossi, Murat Akova, Evelina Tacconelli, (unknown), (unknown), Aleksandra Barać, Dafna Yahav	0
3	Sexual satisfaction, an indicator of sexual health and well-being? Insights from STI/HIV prevention research in European men who have sex with men 2024 ·BMJ Global Health ·Karel Blondeel, Massimo Mirandola, Lorenzo Gios, Cinta Folch, (unknown), (unknown), Petra De Sutter, Marleen Temmerman, Igor Toskin	3
4	Clinic-based evaluation of point-of-care dual HIV/syphilis rapid diagnostic tests at primary healthcare antenatal facilities in South Africa and Zambia 2024 ·BMC Infectious Diseases ·Ranmini Kularatne, Karel Blondeel, Margaret P. Kasaro, Venessa Maseko, Samuel Bosomprah, Ronaldo Silva, Maura Laverty, (unknown), Massimo Mirandola, Rosanna Ŵ. Peeling	4
5	A Digital Approach to Improve Infection Screening Among Solid Organ Transplant Candidates 2024 ·Clinical Transplantation ·Elda Righi, (unknown), Massimo Mirandola, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Francesco Onorati, (unknown), Giovanni Battista Luciani, (unknown), (unknown), (unknown), Alex Borin, Luigino Boschiero, Amedeo Carraro, Evelina Tacconelli	0
6	Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV 2024 ·Journal of Medical Virology ·Akshita Gupta, Elda Righi, (unknown), Concetta Sciammarella, (unknown), (unknown), Matilda Berkell, An Hotterbeekx, Assunta Sartor, Massimo Mirandola, Surbhi Malhotra‐Kumar, Anna Maria Azzini, Diletta Pezzani, Maria Grazia Lourdes Monaco, Guido Vanham, Stefano Porru, Evelina Tacconelli, Samir Kumar‐Singh	2
7	Gut Microbiome Disruption Following SARS-CoV-2: A Review 2024 ·Microorganisms ·Elda Righi, (unknown), Nina Auerbach, (unknown), Anna Górska, Concetta Sciammarella, (unknown), Elisa Gentilotti, Massimo Mirandola, Evelina Tacconelli, Assunta Sartor	6
8	A clinical utility evaluation of dual HIV/Syphilis point-of-care tests in non-clinical settings for screening for HIV and syphilis in men who have sex with men 2024 ·BMC Infectious Diseases ·(unknown), Juliana Reyes‐Urueña, (unknown), (unknown), (unknown), (unknown), (unknown), Victoria González, Karel Blondeel, Soe Soe Thwin, Lorenzo Gios, Massimo Mirandola, Rosanna Ŵ. Peeling, James Kiarie, Jordi Casabona, Igor Toskin, (unknown)	1
9	Body composition and laboratory parameters in children with down syndrome: The DONUT study 2023 ·Clinical Nutrition ESPEN ·Luca Pecoraro, (unknown), (unknown), Massimo Mirandola, Silvana Lauriola, Giorgio Piacentini, Angelo Pietrobelli	5
10	How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2 2023 ·Vaccines ·Anna Maria Azzini, Lorenzo Maria Canziani, Ruth Joanna Davis, Massimo Mirandola, Michael Höelscher, Laurence Meyer, Cédric Laouenan, Maddalena Giannella, Jesús Rodríguez‐Baño, Paolo Boffetta, Dana Mateș, Surbhi Malhotra‐Kumar, Gabriella Scipione, (unknown), Eugenia Rinaldi, Jan Hasenauer, Evelina Tacconelli	6
11	Microaggression toward LGBTIQ people and implications for mental health: A systematic review 2023 ·International Journal of Social Psychiatry ·Mattia Marchi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Luca Pingani, Sílvia Ferrari, Andrea Fiorillo, Manlio Converti, Federica Pinna, Francesco Amaddeo, Antonio Ventriglio, Massimo Mirandola, Gian Maria Galeazzi	8
12	Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy 2023 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Maria Carelli, (unknown), Alessia Savoldi, (unknown), Massimo Mirandola, Maria M. Lleò, Caterina Signoretto, (unknown)	9
13	Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 facilities in a high endemic setting 2023 ·Frontiers in Cellular and Infection Microbiology ·Anna Maria Azzini, (unknown), (unknown), (unknown), Nicola Duccio Salerno, (unknown), Alda Bazaj, Massimo Mirandola, (unknown), Fulvia Mazzaferri, Simone Accordini, Giuliana Lo Cascio, Evelina Tacconelli	1
14	Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study 2022 ·Journal of Infection ·Elda Righi, Massimo Mirandola, Fulvia Mazzaferri, (unknown), (unknown), (unknown), Federico Ivaldi, (unknown), (unknown), (unknown), Claudio Micheletto, Davide Gibellini, Evelina Tacconelli	57
15	Harmonization and standardization of data for a pan-European cohort on SARS- CoV-2 pandemic 2022 ·npj Digital Medicine ·Eugenia Rinaldi, (unknown), (unknown), Natascia Caroccia, (unknown), Maddalena Giannella, (unknown), Massimo Mirandola, Gabriella Scipione, Evelina Tacconelli, Sylvia Thun	18
16	Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern 2022 ·eLife ·Fulvia Mazzaferri, Massimo Mirandola, Alessia Savoldi, Pasquale De Nardo, (unknown), (unknown), (unknown), (unknown), (unknown), Lolita Sasset, (unknown), Emanuela Sozio, Elisa Danese, (unknown), Isabella Monne, Giovanna Scroccaro, Nicola Magrini, Anna Maria Cattelan, Carlo Tascini, (unknown), (unknown)	14
17	What is the empirical basis for converting banded ordinal data on numbers of sex partners among MSM into a continuous scale level variable? A secondary analysis of 13 surveys across 17 countries 2022 ·BMC Medical Research Methodology ·(unknown), Ford Hickson, Klaus Jansen, Nathan J. Lachowsky, Fiona Burns, Cinta Folch, Annie Velter, Peter Weatherburn, Ulrich Marcus, Ursula von Rüden, Massimo Mirandola, Lorenzo Gios, Jamie Frankis, David J. Brennan, Axel J. Schmidt	3
18	State-of-the-art study focusing on the healthinequalities faced by LGBTI people: State-of-the-Art Synthesis Report (SSR) 2017 ·MURAL - Maynooth University Research Archive Library (National University of Ireland, Maynooth) ·Laetitia Zeeman, Nigel Sherriff, Kath Browne, (unknown), (unknown), (unknown), Ruth Davies, Massimo Mirandola, Lorenzo Gios, Francesco Amaddeo, Valeria Donisi, Magdalena Rosińska, Marta Niedźwiedzka-Stadnik, Anne Pierson	2
19	Undiagnosed HIV infection in a population of MSM from six European cities: results from the Sialon project 2014 ·European Journal of Public Health ·Laia Ferrer, Martina Furegato, (unknown), Cinta Folch, Victoria González, Dunia Ramarli, Jordi Casabona, Massimo Mirandola	32
20	Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 1996 ·Clinical Microbiology and Infection ·Mario Cruciani, Elisa Bertazzoni Minelli, Massimo Mirandola, Roberto Luzzati, (unknown), Luca Lazzarini, Giorgio Gatti, Sandro Vento, Romualdo Mazzi, Marina Malena, Anna Benini, Angelo Cazzadori, (unknown), Dante Bassetti, Ercole Concia	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact